• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD; THORAFLEX HYBRID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD; THORAFLEX HYBRID Back to Search Results
Catalog Number THP2426X100J
Device Problem Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/25/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturers narrative: clinical code: 4582-no clinical signs, symptoms or conditions: as reported in intake form no health damage to the patient.Impact code: 2199-no health consequences or impact: as reported in intake form no health damage to the patient.Medical device problem: 3190-insufficient information: site confirmed on 31 oct 23 that no further information is available for this event, device will not be returned for analysis as remains implanted.Component code: 4755-part/component/sub-assembly term not applicable: type of investigation: 4114-device not returned: device remains implanted.3331-analysis of production records: a review of manufacturing and qc records confirmed that there were no issues with the manufacture of the device.4110-trend analysis: a 5-year review of similar complaints (leakage>> blood oozing) gave an occurrence rate of 0.049% (complaints v sales).4119-insufficient information available: site confirmed on 31 oct 23 that no further information is available for this event, device will not be returned for analysis as remains implanted.
 
Event Description
Blood leakage: after anastomosis of the collar, a small amount of blood leakage was observed from the junction when the blood flow was returned.Hydrofit and bioglue were therefore injected to achieve hemostasis.No health damage to the patient.Operation type: tar; blood loss: unknown; no image available; no additional information available; tc no: (b)(4).
 
Event Description
Blood leakage: after anastomosis of the collar, a small amount of blood leakage was observed from the junction when the blood flow was returned.Hydrofit and bioglue were therefore injected to achieve hemostasis.No health damage to the patient.Operation type: tar; blood loss: unknown; no image available.No additional information available tc no: (b)(6).This report is being submitted as a final for mfg.Report #9612515-2023-00032, to provide event closure information for (b)(4).
 
Manufacturer Narrative
Manufacturers narrative.Clinical code: 4582-no clinical signs, symptoms or conditions: as reported in intake form no health damage to the patient.Impact code: 2199-no health consequences or impact: as reported in intake form no health damage to the patient.Medical device problem: 3190-insufficient information: site confirmed on 31 oct 23 that no further information is available for this event, device will not be returned for analysis as remains implanted component code: 4755-part/component/sub-assembly term not applicable.Type of investigation: 4114-device not returned: device remains implanted 3331-analysis of production records: a review of manufacturing and qc records confirmed that there were no issues with the manufacture of the device 4110-trend analysis: a 5-year review of similar complaints (leakage>> blood oozing) gave an occurrence rate of (b)(4) (complaints v sales).4119-insufficient information available: site confirmed on 31 oct 23 that no further information is available for this event, device will not be returned for analysis as remains implanted investigation findings: 3221 - no findings available - device not returned and customer confirmed no further information is available for this event.Investigation conclusions: 4315 - cause not established - a cause could not be established as the product was not returned, the manufacturing records confirm the device was manufactured according to specification, and there is no further information available for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
THORAFLEX HYBRID
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK  PA49RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK   PA49RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan
glasgow, PA49R-R
UK   PA49RR
MDR Report Key18189317
MDR Text Key328737811
Report Number9612515-2023-00032
Device Sequence Number1
Product Code QSK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Remedial Action Repair
Type of Report Initial,Followup
Report Date 12/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTHP2426X100J
Device Lot Number25324181
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-